Overview


Prescription narcotics are a type of drug that has the potential to be addictive. Because of their addictive potential, this type of drug should only be used according to a doctor’s specific prescription. These narcotics are also used as pain killers to relieve pain from the body and this narcotic work in the body by binding themselves to pain receptors in the nervous system so that the pain signals are blocked. As a result, this type of drug is sometimes prescribed to temporarily treat severe pain that doesn’t respond to other forms of pain relievers.

Increasing demand of opioids in clinical practice for treating chronic pain conditions is fuelling the growth of the market. Along with increasing demand, rising prevalence of chronic pain is expected to boost the utilization of narcotics in effective chronic pain treatment. According to CDC, 11% of adult population in the US is experiencing some form of chronic pain. Further, changing regulatory conditions to encourage the utilization of narcotics in better management of pain led to potential growth of the market. Further, opioids are only available effective therapy for severe pains when compared to alternatives treatment options. All these factors led to potential growth of the market during forecast period. 

Global market is dominated by North America market due to supportive regulatory environment. It is expected to remain dominant throughout forecast period and it witnessed a large number of manufacturers. It is followed by Europe market due to high adoption of opioids for effective management of pain. Asia Pacific and Latin America is fast growing region due to increasing adoption of opioids in clinical practice. Further, high prevalence of chronic pain in these regions is expected fuel the growth of the market. Rest of World is also fast-growing region due to increasing adoption among end-user segment led to potential growth of the market.

  • Pfizer Inc
  • Novartis AG
  • J&J
  • Merck Co. & Inc
  • Roche Holding
  • Bayer AG
  • AstraZeneca
  • Sanofi
  • Plc and others

Table of Contents


  • 1.  

    • Introduction
  • 2.  

    Scope and Objective

  • 3.  

    Assumptions and Acronyms

  • 4.  

    Forecast Factors

  • 5.  

    Research Methodology

  • 6.  

    • Executive Summary
  • 7.  

    Industry Cluster Analysis

  • 8.  

    Competition Matrix

  • 9.  

    Strategies Recommendations

  • 10.  

    • Market Definition
  • 11.  

    Report Scope (Inclusions

    • Exclusions)
  • 12.  

    Market Segmentation

  • 13.  

    • Global Market Overview
  • 14.  

    Global Prescription Narcotics Market Revenue (USD Mn)

  • 15.  

    • Key Inclusions
  • 16.  

    Porter’s Five Force analysis

  • 17.  

    Market Dynamics

  • 18.  

    Industry Trends

  • 19.  

    Regulatory Guidelines

  • 20.  

    Opportunities in Prescription Narcotics

  • 21.  

    • Competition Dynamics
  • 22.  

    Company Share Analysis (2019)

  • 23.  

    Top 10 Product Pricing by Region

  • 24.  

    • Global Revenue (USD Mn), 2023-2031 by Indication
  • 25.  

    Key Market Findings

  • 26.  

    Long Term ROI Segments

  • 27.  

    Revenue Opportunity Influencing Factors

  • 28.  

    Market Revenue (USD Mn) Assessment and Forecast by Indication, 2023-2031

  • 29.  

    Cancer Pain

  • 30.  

    Trauma

  • 31.  

    Analgesics

  • 32.  

    Others

  • 33.  

    • Global Market Revenue (USD Mn), 2023-2031 by Sales Channel
  • 34.  

    Key Market Findings

  • 35.  

    Long Term ROI Segments

  • 36.  

    Revenue Opportunity Influencing Factors

  • 37.  

    Market Revenue (USD Mn) Assessment and Forecast by Sales Channel, 2023-2031

  • 38.  

    Retail Pharmacies

  • 39.  

    Institutional Distribution

  • 40.  

    • Global Revenue (USD Mn), 2023-2031 by Region
  • 41.  

    Key Market Findings

  • 42.  

    Long Term ROI Segments

  • 43.  

    Revenue Opportunity Influencing Factors

  • 44.  

    Market Revenue (USD Mn) Assessment and Forecast by Region,2026

  • 45.  

    North America

  • 46.  

    Latin America

  • 47.  

    Europe

  • 48.  

    Asia Pacific

  • 49.  

    Rest of world

  • 50.  

    • North America Market Revenue (US$ Mn), 2023-2031
  • 51.  

    Key Market Findings

  • 52.  

    Long Term ROI Segments

  • 53.  

    Revenue Opportunity Influencing Factors

  • 54.  

    Market Revenue (USD Mn) Assessment and Forecast by Country, 2023-2031

  • 55.  

    US

  • 56.  

    Canada

  • 57.  

    Market Revenue (USD Mn) Assessment and Forecast by Indication, 2023-2031

  • 58.  

    Cancer Pain

  • 59.  

    Trauma

  • 60.  

    Analgesics

  • 61.  

    Others

  • 62.  

    Market Revenue (USD Mn) Assessment and Forecast by Sales Channel, 2023-2031

  • 63.  

    Retail Pharmacies

  • 64.  

    Institutional Distribution

  • 65.  

    • Latin America Market Revenue (US$ Mn), 2023-2031
  • 66.  

    Key Market Findings

  • 67.  

    Long Term ROI Segments

  • 68.  

    Revenue Opportunity Influencing Factors

  • 69.  

    Market Revenue (USD Mn) Assessment and Forecast by Country, 2023-2031

  • 70.  

    Brazil

  • 71.  

    Mexico

  • 72.  

    Argentina

  • 73.  

    Rest of Latin America

  • 74.  

    Market Revenue (USD Mn) Assessment and Forecast by Indication, 2023-2031

  • 75.  

    Cancer Pain

  • 76.  

    Trauma

  • 77.  

    Analgesics

  • 78.  

    Others

  • 79.  

    Market Revenue (USD Mn) Assessment and Forecast by Sales Channel, 2023-2031

  • 80.  

    Retail Pharmacies

  • 81.  

    • Institutional Distribution
  • 82.  

    • Europe Market Revenue (US$ Mn), 2023-2031
  • 83.  

    Key Market Findings

  • 84.  

    Long Term ROI Segments

  • 85.  

    Revenue Opportunity Influencing Factors

  • 86.  

    Market Revenue (USD Mn) Assessment and Forecast by Country, 2023-2031

  • 87.  

    Germany

  • 88.  

    France

  • 89.  

    Spain

  • 90.  

    UK

  • 91.  

    Russia

  • 92.  

    Poland

  • 93.  

    Rest of Europe

  • 94.  

    Market Revenue (USD Mn) Assessment and Forecast by Indication, 2023-2031

  • 95.  

    Cancer Pain

  • 96.  

    Trauma

  • 97.  

    Analgesics

  • 98.  

    Others

  • 99.  

    Market Revenue (USD Mn) Assessment and Forecast by Sales Channel, 2023-2031

  • 100.  

    Retail Pharmacies

  • 101.  

    Institutional Distribution

  • 102.  

    • Asia Pacific Market Revenue (US$ Mn), 2023-2031
  • 103.  

    Key Market Findings

  • 104.  

    Long Term ROI Segments

  • 105.  

    Revenue Opportunity Influencing Factors

  • 106.  

    Market Revenue (USD Mn) Assessment and Forecast by Country, 2023-2031

  • 107.  

    Emerging Asia

  • 108.  

    China

  • 109.  

    India

  • 110.  

    ASEAN-5

  • 111.  

    Rest of Emerging Asia

  • 112.  

    Japan

  • 113.  

    Market Revenue (USD Mn) Assessment and Forecast by Indication, 2023-2031

  • 114.  

    Cancer Pain

  • 115.  

    Trauma

  • 116.  

    Analgesics

  • 117.  

    Others

  • 118.  

    Market Revenue (USD Mn) Assessment and Forecast by Sales Channel, 2023-2031

  • 119.  

    Retail Pharmacies

  • 120.  

    Institutional Distribution

  • 121.  

    • Rest of World Market Revenue (US$ Mn), 2023-2031
  • 122.  

    Key Market Findings

  • 123.  

    Long Term ROI Segments

  • 124.  

    Revenue Opportunity Influencing Factors

  • 125.  

    Market Revenue (USD Mn) Assessment and Forecast by Country, 2023-2031

  • 126.  

    Middle East

  • 127.  

    South Africa

  • 128.  

    North Africa

  • 129.  

    Rest of World

  • 130.  

    Market Revenue (USD Mn) Assessment and Forecast by Indication, 2023-2031

  • 131.  

    Cancer Pain

  • 132.  

    Trauma

  • 133.  

    Analgesics

  • 134.  

    Others

  • 135.  

    Market Revenue (USD Mn) Assessment and Forecast by Sales Channel, 2023-2031

  • 136.  

    Retail Pharmacies

  • 137.  

    • Institutional Distribution
  • 138.  

    • Company Profiles
  • 139.  

    Competition Landscape

  • 140.  

    Global Company Share (USD Mn) Overview, 2019

  • 141.  

    Company Profiles

  • 142.  

    Pfizer Inc

  • 143.  

    Corporate Overview

  • 144.  

    Financial Performance

  • 145.  

    Peer Comparison

    • 3C marketing equation
  • 146.  

    Company Strategy

    • Channel Management
  • 147.  

    Novartis AG

  • 148.  

    Corporate Overview

  • 149.  

    Financial Performance

  • 150.  

    Peer Comparison

    • 3C marketing equation
  • 151.  

    Company Strategy

    • Channel Management
  • 152.  

    J J

  • 153.  

    Corporate Overview

  • 154.  

    Financial Performance

  • 155.  

    Peer Comparison

    • 3C marketing equation
  • 156.  

    Company Strategy

    • Channel Management
        

      Merck Co.
      Inc

  • 157.  

    Corporate Overview

  • 158.  

    Financial Performance

  • 159.  

    Peer Comparison

    • 3C marketing equation
  • 160.  

    Company Strategy

    • Channel Management
  • 161.  

    Roche Holding

  • 162.  

    Corporate Overview

  • 163.  

    Financial Performance

  • 164.  

    Peer Comparison

    • 3C marketing equation
  • 165.  

    Company Strategy

    • Channel Management
  • 166.  

    Bayer AG

  • 167.  

    Corporate Overview

  • 168.  

    Financial Performance

  • 169.  

    Peer Comparison

    • 3C marketing equation
  • 170.  

    Company Strategy

    • Channel Management
  • 171.  

    AstraZeneca

  • 172.  

    Corporate Overview

  • 173.  

    Financial Performance

  • 174.  

    Peer Comparison

    • 3C marketing equation
  • 175.  

    Company Strategy

    • Channel Management
  • 176.  

    Sanofi Plc

  • 177.  

    Corporate Overview

  • 178.  

    Financial Performance

  • 179.  

    Peer Comparison

    • 3C marketing equation
  • 180.  

    Company Strategy

    • Channel Management
  • 181.  

    • Research Sources
      Primary Verbatim

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11